Stay updated with breaking news from Genevant Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Companies seek compensation for Pfizer’s and BioNTech’s unlicensed use of patented technologies in COVID-19 mRNA-LNP vaccines WARMINSTER, Pa., April 04, 2023 -- Arbutus... | April 4, 2023
The lawsuit by Arbutus and Genevant says Pfizer/BioNTech engaged in licensing discussions for the technology but they did not "result in a settlement."
By Will Feuer Arbutus Biopharma Corp. and its licensee Genevant Sciences have filed a patent-infringement lawsuit against Pfizer Inc. and BioNTech SE related to the latter's Covid-19 vaccine.... | April 4, 2023
/cloudfront-us-east-1.images.arcpublishing.com/tgam/FACKBSO5HVF3RA7T4VPG4TJJ3E.jpg)
Companies find new digs in a vibrant tech cluster close to hospitals and transit
By Will Feuer Arbutus Biopharma Corp. and its licensee Genevant Sciences have filed a patent-infringement lawsuit against Pfizer Inc. and BioNTech SE related to the latter's Covid-19 vaccine.... | April 4, 2023